FuseFISH: Robust detection of transcribed gene fusions in single cells

Cell Reports

Volumn 6, Issue 1, 2014, Pages 18-23

  Semrau, Stefan ^a   Crosetto, Nicola ^a,f   Bienko, Magda ^a,f   Boni, Marina ^b   Bernasconi, Paolo ^b   Chiarle, Roberto ^c,d,e   vanOudenaarden, Alexander ^a,f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL TISSUE; ARTICLE; BCR ABL1 FUSION GENE; CANCER SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEASIBILITY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSE FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE FUSION; GENE SEQUENCE; GENETIC DATABASE; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RNA ANALYSIS; RNA PURIFICATION; SENSITIVITY AND SPECIFICITY; SINGLE CELL ANALYSIS; VALIDATION PROCESS;

CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; FUSION PROTEINS, BCR-ABL; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84892509630     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.12.002     Document Type: Article

References (22)

1. Alpár D., Hermesz J., Pótó L., László R., Kereskai L., Jáksó P., Pajor G., Pajor L., Kajtár B. Automated FISH analysis using dual-fusion and break-apart probes on paraffin-embedded tissue sections. Cytometry A 2008, 73:651-657.
2. Baccarani M., Cortes J., Pane F., Niederwieser D., Saglio G., Apperley J., Cervantes F., Deininger M., Gratwohl A., Guilhot F., et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J.Clin. Oncol. 2009, 27:6041-6051. European LeukemiaNet.
3. Bienko M., Crosetto N., Teytelman L., Klemm S., Itzkovitz S., van Oudenaarden A. A versatile genome-scale PCR-based pipeline for high-definition DNA FISH. Nat. Methods 2013, 10:122-124.
4. Femino A.M., Fay F.S., Fogarty K., Singer R.H. Visualization of single RNA transcripts insitu. Science 1998, 280:585-590.
5. Fröhling S., Döhner H. Chromosomal abnormalities in cancer. N.Engl. J. Med. 2008, 359:722-734.
6. Kantarjian H., Schiffer C., Jones D., Cortes J. Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods. Blood 2008, 111:1774-1780.
7. La Thangue N.B., Kerr D.J. Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat. Rev. Clin. Oncol. 2011, 8:587-596.
8. Lerner B., Clocksin W.F., Dhanjal S., Hultén M.A., Bishop C.M. Automatic signal classification in fluorescence insitu hybridization images. Cytometry 2001, 43:87-93.
9. Maher C.A., Kumar-Sinha C., Cao X., Kalyana-Sundaram S., Han B., Jing X., Sam L., Barrette T., Palanisamy N., Chinnaiyan A.M. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458:97-101.
10. Marusyk A., Almendro V., Polyak K. Intra-tumour heterogeneity: a looking glass for cancer?. Nat. Rev. Cancer 2012, 12:323-334.
11. Melo J.V., Barnes D.J. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat. Rev. Cancer 2007, 7:441-453.
12. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
13. Rabbitts T.H. Commonality but diversity in cancer gene fusions. Cell 2009, 137:391-395.
14. Radich J.P. How I monitor residual disease in chronic myeloid leukemia. Blood 2009, 114:3376-3381.
15. Raj A., van den Bogaard P., Rifkin S.A., van Oudenaarden A., Tyagi S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat. Methods 2008, 5:877-879.
16. Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer 2005, 5:172-183.
17. Rowley J.D. Chromosomes in leukemia and beyond: from irrelevant to central players. Annu. Rev. Genomics Hum. Genet. 2009, 10:1-18.
18. Schiffer C.A. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N.Engl. J. Med. 2007, 357:258-265.
19. Semrau S., Holtzer L., González-Gaitán M., Schmidt T. Quantification of biological interactions with particle image cross-correlation spectroscopy (PICCS). Biophys. J. 2011, 100:1810-1818.
20. Shirley J.W., Ty S., Takebayashi S.-I., Liu X., Gilbert D.M. FISH Finder: a high-throughput tool for analyzing FISH images. Bioinformatics 2011, 27:933-938.
21. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S.-I., Watanabe H., Kurashina K., Hatanaka H., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
22. Waks Z., Klein A.M., Silver P.A. Cell-to-cell variability of alternative RNA splicing. Mol. Syst. Biol. 2011, 7:506.